For example, both semaglutide and tirzepatide, in addition to their primary indications for type 2 diabetes and obesity, have demonstrated cardiovascular benefits
Key takeaways GLP-1 agonists are a class of drugs that were originally designed to treat type 2 diabetes, but their use has expanded to include weight loss, heart and kidney disease risk reduction, and management of obstructive sleep apnea
Ca2+-dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid -treated astrocytes and in a model of alzheimers disease
The GLP-1 dose conversion chart A dose conversion chart helps clinicians and patients switch between different GLP-1 agents while maintaining a therapeutic effect
Reviewers frequently reject requests when providers fail to document specific BMI measurements, comorbidity diagnoses, or adequate timeline of weight loss intervention attempts